This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock CANB vs. MEDS, BIMI, HCWB, ATNF, FRTX, NRBO, IMCC, BGLC, QNRX, and KTTAShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), HCW Biologics (HCWB), 180 Life Sciences (ATNF), Fresh Tracks Therapeutics (FRTX), NeuroBo Pharmaceuticals (NRBO), IM Cannabis (IMCC), BioNexus Gene Lab (BGLC), Quoin Pharmaceuticals (QNRX), and Pasithea Therapeutics (KTTA). These companies are all part of the "medical" sector. Can B vs. Its Competitors TRxADE HEALTH BIMI HCW Biologics 180 Life Sciences Fresh Tracks Therapeutics NeuroBo Pharmaceuticals IM Cannabis BioNexus Gene Lab Quoin Pharmaceuticals Pasithea Therapeutics Can B (NASDAQ:CANB) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Does the media refer more to CANB or MEDS? In the previous week, TRxADE HEALTH had 1 more articles in the media than Can B. MarketBeat recorded 1 mentions for TRxADE HEALTH and 0 mentions for Can B. TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the news media. Company Overall Sentiment Can B Neutral TRxADE HEALTH Neutral Which has higher valuation and earnings, CANB or MEDS? Can B has higher earnings, but lower revenue than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCan B$2.16M0.58-$9.74MN/AN/ATRxADE HEALTH$7.45M0.27-$17.84MN/AN/A Which has more volatility and risk, CANB or MEDS? Can B has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500. Is CANB or MEDS more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets Can B-1,238.33% N/A -218.65% TRxADE HEALTH -149.81%-196.79%-112.21% Do institutionals and insiders believe in CANB or MEDS? 6.1% of Can B shares are held by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are held by institutional investors. 11.4% of Can B shares are held by company insiders. Comparatively, 48.4% of TRxADE HEALTH shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryTRxADE HEALTH beats Can B on 7 of the 11 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.26M$2.79M$5.52B$9.02BDividend YieldN/AN/A5.24%4.05%P/E RatioN/AN/A27.2520.08Price / Sales0.580.27371.3293.25Price / CashN/AN/A26.2128.59Price / Book-0.053.227.945.55Net Income-$9.74M-$17.84M$3.17B$248.49M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.02+2.7%N/A+46.0%$1.26M$2.16M0.0016Gap UpMEDSTRxADE HEALTHN/A$1.04+11.2%N/A-91.4%$1.46M$7.45M0.0050BIMIBIMIN/A$0.00flatN/AN/A$1K$12.63M0.00520HCWBHCW Biologics3.3269 of 5 stars$3.75-5.3%$35.00+833.3%-83.2%$5.71M$2.57M-0.1640ATNF180 Life Sciences0.5821 of 5 stars$0.89-4.1%N/A-48.7%$5.63MN/A0.007FRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A-0.5%$5.59M$10.06M-0.6620NRBONeuroBo PharmaceuticalsN/A$0.64+2.1%N/A-85.7%$5.54MN/A0.0010Gap UpIMCCIM Cannabis0.334 of 5 stars$2.70+8.9%N/A+31.3%$5.54M$39.44M-4.22340BGLCBioNexus Gene Lab0.4191 of 5 stars$11.14+262.9%N/A+27.8%$5.52M$9.51M0.0030High Trading VolumeQNRXQuoin Pharmaceuticals0.5201 of 5 stars$9.23flatN/A-56.2%$5.43MN/A-0.194KTTAPasithea Therapeutics0.99 of 5 stars$0.73+1.8%N/A-85.9%$5.37MN/A-0.073Positive News Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors HCWB Competitors ATNF Competitors FRTX Competitors NRBO Competitors IMCC Competitors BGLC Competitors QNRX Competitors KTTA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CANB) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
